Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) EBT (2016 - 2025)

Historic EBT for Neogen (NEOG) over the last 16 years, with Q4 2025 value amounting to -$20.4 million.

  • Neogen's EBT rose 9572.7% to -$20.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$617.5 million, marking a year-over-year decrease of 2241.92%. This contributed to the annual value of -$1.1 billion for FY2025, which is 782107.65% down from last year.
  • As of Q4 2025, Neogen's EBT stood at -$20.4 million, which was up 9572.7% from $43.8 million recorded in Q3 2025.
  • Neogen's EBT's 5-year high stood at $43.8 million during Q3 2025, with a 5-year trough of -$631.2 million in Q2 2025.
  • In the last 5 years, Neogen's EBT had a median value of -$298500.0 in 2023 and averaged -$52.5 million.
  • Per our database at Business Quant, Neogen's EBT crashed by 1261876.17% in 2024 and then soared by 38065.86% in 2025.
  • Quarter analysis of 5 years shows Neogen's EBT stood at $12.9 million in 2021, then crashed by 363.7% to -$34.1 million in 2022, then soared by 89.01% to -$3.7 million in 2023, then plummeted by 12618.76% to -$476.6 million in 2024, then skyrocketed by 95.73% to -$20.4 million in 2025.
  • Its EBT stands at -$20.4 million for Q4 2025, versus $43.8 million for Q3 2025 and -$631.2 million for Q2 2025.